Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet's disease

Clinical Rheumatology

Volumn 27, Issue 12, 2008, Pages 1529-1534

  Taysi, Seyithan ^a   Sari, Refik Ali ^b   Dursun, Hakan ^b   Yilmaz, Adnan ^c   Keles, Mustafa ^b   Cayir, Kerim ^b   Akyuz, Mehmet ^b   Uyanik, Abdullah ^b   Guvenc, Adem ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

^c Nenehatun Obstetric and Gynecology Hospital ^*  (Turkey)

Author keywords

Free radicals; Homocysteine; Nitric oxide; Nitric oxide synthase; Oxidative stress

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BEHCET DISEASE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BEHCET SYNDROME; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ERYTHROCYTES; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; OXIDATIVE STRESS; YOUNG ADULT;

EID: 56349151740     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-0963-4     Document Type: Article

References (42)

1. Behcet H (1937) Uber residivietende apththose, durch ein virus verursachte geschwura am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152-1157
2. Taysi S, Demircan B, Akdeniz N, Atasoy M, Sari RA (2007) Oxidant/ antioxidant status in men with Behcet's disease. Clin Rheumatol 26:418-422
3. Taysi S, Kocer I, Memisogullari R, Kiziltunc A (2002) Serum oxidant/ antioxidant status in patients with Behcet's disease. Ann Clin Lab Sci 32:377-382
4. Watanabe K, Ohashi Y (1984) Natural killer cell activity in patients with Behcet's disease. Am J Ophthalmol 98:813-814
5. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet's disease. N Engl J Med 341:1284-1291
6. Nussenblatt RBWS, Palestine AG (1996) Uveitis: Fundamentals and clinical practice. Mosby, St. Louis, pp 334-353
7. El-Ageb EM, Al-Maini MH, Al-Shukaily AK, Al-Farsi Y, Richens ER (2002) Clinical features of Behcet's disease in patients in the Sultanate of Oman; the significance of antiphospholipid antibodies? Rheumatol Int 21:176-181
8. Aktan B, Taysi S, Gumustekin K, Bakan N, Sutbeyaz Y (2003) Evaluation of oxidative stress in erythrocytes of guinea pigs with experimental otitis media and effusion. Ann Clin Lab Sci 33:232-236
9. Memisogullari R, Taysi S, Bakan E, Capoglu I (2003) Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct 21:291-296
10. Taysi S, Gul M, Sari RA, Akcay F, Bakan N (2002) Serum oxidant/ antioxidant status of patients with systemic lupus erythematosus. Clin Chem Lab Med 40:684-688
11. Akkus I, Kalak S, Vural H, Caglayan O, Menekse E, Can G, Durmus B (1996) Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin Chim Acta 244:221-227
12. Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200-204
13. Ezirmik N, Taysi S, Celik R, Celik G, Alici HA, Turhan H, Cesur M, Keskin D (2008) Oxidant/antioxidant status in pneumatic tourniquet-induced ischemia-reperfusion in meniscal patients undergoing arthroscopy. Asian J Chem 20:1950-1956
14. Maeda H, Akaike T (1998) Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 63:854-865
15. Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, Gumus M (2002) Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 32:162-166
16. Yildiz M, Taysi S, Umudum Z (2008) Nitric oxide synthase activity in erythrocyte of the rabbits which implanted composite resin filling materials into connective tissue. Asian J Chem 20:3902-3906
17. Vazgiourakis V, Sidiropoulos P, Bertsias G, Koutsounaki E, Fragouli E, Raptopoulou A, Kritikos H, Boumpas DT, Goulielmos GN (2007) Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population. Lupus 16(11):867-874
18. Rasmussen K, Moller J (2000) Total homocysteine measurement in clinical practice. Ann Clin Biochem 37:627-648
19. Undas A, Brozek J, Szczeklik A (2005) Homocysteine and thrombosis: From basic science to clinical evidence. Thromb Haemost 94:907-915
20. Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simsek B (2007) Assessment of homocysteine, neopterin and nitric oxide levels in Behcet's disease. Clin Chem Lab Med 45:73-77
21. van Guldener C, Stehouwer CD (2000) Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 26:281-289
22. Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 6:27-36
23. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
24. Durak I, Ozturk HS, Elgun S, Cimen MY, Yalcin S (2001) Erythrocyte nitric oxide metabolism in patients with chronic renal failure. Clin Nephrol 55:460-464
25. Moshage H, Kok B, Huizenga JR, Jansen PL (1995) Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 41:892-896
26. Kose K, Yazici C, Assioglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet's disease. Clin Biochem 34:125-129
27. Kose K, Dogan P, Ascioglu M, Erkilic K, Ascioglu O (1995) Oxidative stress and antioxidant defenses in plasma of patients with Behcet's disease. Tohoku J Exp Med 176:239-248
28. Demirbag R, Yilmaz R, Guzel S, Celik H, Kocyigit A, Ozcan E (2006) Effects of treadmill exercise test on oxidative/antioxidative parameters and DNA damage. Anadolu Kardiyol Derg 6:135-140
29. Mangoni AA, Jackson SH (2002) Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 112:556-565
30. Alvarez-Maqueda M, El Bekay R, Monteseirin J, Alba G, Chacon P, Vega A, Santa Maria C, Tejedo JR, Martin-Nieto J, Bedoya FJ, Pintado E, Sobrino F (2004) Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis 172:229-238
31. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057
32. Loscalzo J (1996) The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98:5-7
33. Wu LL, Wu JT (2002) Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 322:21-28
34. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, Sehlub J, Virtamo J, Taylor PR (1999) Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91:535-541
35. Feki M, Houman H, Ghannouchi M, Smiti-Khanfir M, Hamzaoui K, El Matri L, Mebazaa A, Kaabachi N (2004) Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet's disease. Clin Chem Lab Med 42:1417-1423
36. Calikoglu E, Oztas M, Sengul N, Adam B, Gurer MA (2002) Serum homocysteine level in Behcet's disease. Haematologia (Budap) 32:219-224
37. Kiraz S, Ertenli I, Calguneri M, Ozturk MA, Haznedaroglu IC, Altun B, Erman M, Celik I (2001) Interactions of nitric oxide and superoxide dismutase in Behcet's disease. Clin Exp Rheumatol 19:S25-S29
38. Akdeniz N, Esrefoglu M, Keles MS, Karakuzu A, Atasoy M (2004) Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Ann Acad Med Singapore 33:596-599
39. Orem A, Vanizor B, Cimsit G, Kiran E, Deger O, Malkoc M (1999) Decreased nitric oxide production in patients with Behcet's disease. Dermatol 198:33-36
40. Buldanlioglu S, Turkmen S, Ayabakan HB, Yenice N, Vardar M, Dogan S, Mercan E (2005) Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behcet's disease. Br J Dermatol 153:526-530
41. Aktan B, Taysi S, Gumustekin K, Ucuncu H, Memisogullari R, Save K, Bakan N (2003) Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion. Pol J Pharmacol 55:1105-1110
42. Bakan N, Taysi S, Yilmaz O, Bakan E, Kuskay S, Uzun N, Gundogdu M (2003) Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia. Clin Chim Acta 338:143-149